New and Emerging Therapies for Pediatric Atopic Dermatitis

Paediatric Drugs
Henry L NguyenMegha M Tollefson

Abstract

Atopic dermatitis (AD) is a chronic, inflammatory skin disease characterized by pruritus, inflammatory erythematous skin lesions, and skin-barrier defect. Current mainstay treatments of emollients, steroids, calcineurin inhibitors, and immunosuppressants have limited efficacy and potentially serious side effects. Recent advances and understanding of the pathogenesis of AD have resulted in new therapies that target specific pathways with increased efficacy and the potential for less systemic side effects. New FDA-approved therapies for AD are crisaborole and dupilumab. The JAK-STAT inhibitors (baricitinib, upadacitinib, PF-04965842, ASN002, tofacitinib, ruxolitinib, and delgocitinib) have the most promising results of the emerging therapies. Other drugs with potential include the aryl hydrocarbon receptor modulating agent tapinarof, the IL-4/IL-13 antagonists lebrikizumab and tralokinumab, and the IL-31Rα antagonist nemolizumab. In this review, new and emerging AD therapies will be discussed along with their mechanisms of action and their potential based on clinical study data.

References

Dec 1, 1993·Current Opinion in Immunology·D Y Leung
Jul 1, 1996·The Journal of Investigative Dermatology·J M HanifinE S Weiner
May 23, 1998·Annual Review of Immunology·W J Leonard, J J O'Shea
Mar 22, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·S ShahabuddinR P Schleimer
Nov 13, 2001·American Journal of Respiratory and Critical Care Medicine·E S Schulman
Jul 9, 2002·The British Journal of Dermatology·M ToyodaM Morohashi
Jul 4, 2003·The Journal of Investigative Dermatology·Heinrich DickelThomas L Diepgen
Mar 26, 2004·Transplantation Proceedings·D CattaneoG Remuzzi
Aug 17, 2004·Immunity·Kerstin WolkRobert Sabat
Oct 28, 2005·Journal of the American Society of Nephrology : JASN·Björn WikströmYuji Ueno
Nov 9, 2005·The Journal of Experimental Medicine·Tomoki ItoYong-Jun Liu
Nov 23, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Takaaki NegishiShoji Furusako
Feb 21, 2006·Journal of the American Academy of Dermatology·Aerlyn G Dawn, Gil Yosipovitch
Aug 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Takahiro SatohMasataka Nakamura
Jan 9, 2007·The Journal of Allergy and Clinical Immunology·Paul J DunfordRobin L Thurmond
May 22, 2007·The Journal of Allergy and Clinical Immunology·Michael D HowellDonald Y M Leung
Jan 2, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Byung Eui KimMichael D Howell
Mar 26, 2008·Nature·Francisco J QuintanaHoward L Weiner
Jul 24, 2008·Experimental Dermatology·Kristine RossbachWolfgang Bäumer
Dec 11, 2008·International Immunology·Stefen A BoehmeKevin B Bacon
May 15, 2009·The Journal of Allergy and Clinical Immunology·Kristine E NogralesEmma Guttman-Yassky
May 28, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·H YaharaH Yokozeki
Oct 3, 2009·The New England Journal of Medicine·Arnaud Duval, Louis Dubertret
Aug 4, 2010·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Peter Maximilian HeilGeorg Stingl
Nov 3, 2010·The British Journal of Dermatology·N BookenJ Utikal
Jan 12, 2011·The British Journal of Dermatology·H L Tey, G Yosipovitch
Jun 16, 2011·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·S P JariwalaT Zheng
Aug 5, 2011·The New England Journal of Medicine·Jonathan CorrenJohn G Matthews
Sep 29, 2011·Molecular Immunology·Yuki MatsushimaHiroo Yokozeki
Oct 15, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Jean-Hilaire SauratOlivier Sorg
Dec 20, 2011·Journal of the American Academy of Dermatology·Tiago TorresMargarida Lima
Apr 5, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John Mascarenhas, Ronald Hoffman

❮ Previous
Next ❯

Citations

May 8, 2020·Dermatologic Therapy·Mauro IannelliGiovanni B Pajno
Nov 27, 2019·The British Journal of Dermatology·C Sibbald
Oct 21, 2020·Expert Opinion on Biological Therapy·Rima GhamrawiSteven R Feldman
Mar 5, 2021·Pharmacology & Therapeutics·Xiaoliang YangKenji Kabashima
May 4, 2021·Annals of Dermatology·Jiyoung AhnEric Lawrence Simpson
Jul 17, 2021·Clinical Pharmacology and Therapeutics·Mohamed A KamalJohn D Davis
Sep 18, 2021·Frontiers in Pharmacology·Ting ZhengDi Yu
Feb 9, 2020·Annales de dermatologie et de vénéréologie·E Delaporte

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

Annales de dermatologie et de vénéréologie
J-P Lacour
Dermatologic Therapy
Annunziata DattolaSteven Paul Nisticò
Experimental and Therapeutic Medicine
Diana Deleanu, Irena Nedelea
Archivum Immunologiae Et Therapiae Experimentalis
Mara Giavina-Bianchi, Pedro Giavina-Bianchi
Seminars in Cutaneous Medicine and Surgery
Eric SimpsonL F Eichenfield
© 2021 Meta ULC. All rights reserved